Michael Yee

Stock Analyst at Jefferies

(3.08)
# 1,341
Out of 5,044 analysts
78
Total ratings
43.4%
Success rate
14.08%
Average return

Stocks Rated by Michael Yee

ALX Oncology Holdings
Mar 6, 2025
Upgrades: Buy
Price Target: $2$3
Current: $1.59
Upside: +88.68%
Kodiak Sciences
Dec 9, 2024
Upgrades: Buy
Price Target: $20
Current: $18.93
Upside: +5.65%
Biogen
Dec 9, 2024
Downgrades: Hold
Price Target: $250$180
Current: $147.86
Upside: +21.74%
Vertex Pharmaceuticals
Dec 9, 2024
Upgrades: Buy
Price Target: $500$550
Current: $417.21
Upside: +31.83%
Amgen
Nov 12, 2024
Maintains: Buy
Price Target: $380
Current: $291.77
Upside: +30.24%
Denali Therapeutics
Nov 1, 2024
Maintains: Buy
Price Target: $40$45
Current: $16.25
Upside: +176.92%
Moderna
Oct 15, 2024
Maintains: Hold
Price Target: $65$55
Current: $24.70
Upside: +122.67%
MBX Biosciences
Oct 8, 2024
Initiates: Buy
Price Target: $35
Current: $19.52
Upside: +79.30%
Oruka Therapeutics
Sep 13, 2024
Initiates: Buy
Price Target: $40
Current: $27.61
Upside: +44.88%
Axon Enterprise
Jul 17, 2024
Initiates: Buy
Price Target: $385
Current: $759.44
Upside: -49.30%
Upgrades: Buy
Price Target: $1.4$10
Current: $5.26
Upside: +90.11%
Downgrades: Hold
Price Target: $16$3
Current: $6.25
Upside: -52.00%
Downgrades: Hold
Price Target: $75$30
Current: $24.77
Upside: +21.11%
Downgrades: Hold
Price Target: $60$20
Current: $16.81
Upside: +18.98%
Upgrades: Buy
Price Target: $8$20
Current: $29.27
Upside: -31.67%
Upgrades: Buy
Price Target: $63$75
Current: $8.61
Upside: +771.08%
Initiates: Buy
Price Target: $30
Current: $7.37
Upside: +307.06%
Initiates: Buy
Price Target: $65
Current: $32.85
Upside: +97.87%
Downgrades: Hold
Price Target: $1,875$1,125
Current: $10.91
Upside: +10,211.64%
Downgrades: Hold
Price Target: $40$30
Current: $2.87
Upside: +945.30%
Upgrades: Buy
Price Target: $15$30
Current: $10.65
Upside: +181.69%
Downgrades: Hold
Price Target: $120
Current: $30.99
Upside: +287.22%
Upgrades: Buy
Price Target: $70$75
Current: $21.15
Upside: +254.61%
Initiates: Buy
Price Target: $30
Current: $77.05
Upside: -61.06%
Assumes: Buy
Price Target: $77
Current: $19.78
Upside: +289.28%
Upgrades: Buy
Price Target: n/a
Current: $118.50
Upside: -